Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double homeobox A pseudogene 3 (DUXAP3) is classified as a pseudogene in humans, mapped to chromosome 10, and is part of the DUXA homeobox gene family. Homeobox genes generally code for DNA-binding proteins with a homeodomain of 60–63 amino acids, commonly involved in early embryonic development. However, DUXAP3 lacks evidence of producing a functional protein and is regarded as a non-functional genetic locus (pseudogene). There are no established biological functions, disease associations, or links to drug interaction for DUXAP3. This locus is primarily referenced in genome annotation resources and gene catalogues, with no current role as a molecular or therapeutic target.
None known; no drugs target this pseudogene
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double homeobox A pseudogene 3 (DUXAP3).